Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Eris Lifesciences Financial Results

Eris Lifesciences reported audited FY26 results and declared an interim dividend of Rs. 7.21 per share. The company recorded consolidated annual net profit of ₹647.51 Crore.

Key figures
Value₹7.21 Cr
Source

BSE filing, NSE: ERIS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Eris Lifesciences Ltd: key numbers

Share price
₹1,175.40
Market cap
₹16,307 Cr
Revenue (annual)
₹3,129 Cr
Net profit (annual)
₹619.5 Cr
P/E (TTM)
23.1×Sector 46.1×
Promoter holding
54.74%+0.60% QoQ
FII holding
5.74%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Eris Lifesciences Ltd

All →

Other financial results announcements

All →